WebFocus on prescription pharmaceuticals, focus on innovative products, and focus on 1–2 therapeutic areas. ... GlaxoSmithKline (GSK) and Johnson & Johnson are setting their consumer health businesses free. Pfizer and Novartis are separating out their established products and generics businesses, as Sanofi did with the sale of Zentiva a few ... WebMar 21, 2024 · Mar 14, 2024. The statistic shows GlaxoSmithKline's pharmaceuticals revenues from 2024 to 2024, by therapeutic area. GlaxoSmithKline plc is one of the largest pharmaceutical companies …
23andMe Announces Extension of GSK Collaboration and Update
WebJul 15, 2024 · Post separation, New GSK will focus across four core therapeutic areas (TAs): Infectious Diseases, HIV, Oncology and Immunology/Respiratory. WebApr 11, 2024 · Adaptimmune and GSK are collaborating to transition materials and data relating to the preclinical PRAME targeted TCR T-cell therapy program to Adaptimmune during 2024. Adaptimmune and GSK are targeting transfer of sponsorship for GSK IGNYTE-ESO clinical trial (NCT03967223) and long-term follow-up clinical trial (NCT03391778) … does oregon teach crt
Marek Honczarenko, MD, PhD - LinkedIn
WebTo get ahead of disease, we prioritise research into vaccines and medicines across our four therapeutic areas. We also remain open to opportunities outside these core areas … WebUnder the collaboration, Astex applied its fragment chemistry platform, Pyramid™, to multiple targets identified by GSK, with the objective of identifying and developing new candidate drugs. The targets were selected from multiple therapeutic areas within GSK. GSK are progressing potential drug candidates derived from the collaboration; the ... WebJan 18, 2024 · The CD96 program is an immuno-oncology therapeutic mAb targeting CD96 called GSK’608. ... currently pursuing drug discovery programs rooted in human genetics across a spectrum of disease areas ... does oregon university have a medical school